Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 34 results for "sanofi"

Buy Sanofi India; target of Rs 6000: Dolat Capital
Money Control

Buy Sanofi India; target of Rs 6000: Dolat Capital

Dolat Capital is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 6000 in its research report dated April 13, 2018. Money Control, 2 days ago
Hold Sanofi India; target of Rs 5160: Centrum Money Control, 1 month ago

15 images for sanofi

Money Control, 2 days ago
Money Control, 2 days ago
Business Standard, 2 weeks ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Money Control, 1 month ago
Business Standard, 2 months ago
Business Standard, 2 months ago
Money Control, 2 months ago
Money Control, 2 months ago
Business Standard

Torrent Pharmaceuticals drops plan to buy Sanofi's Europe business

Company was in talks with PE firms to raise funds Sohini Das | Ahmedabad Last Updated at April 5, 2018 01:13 IST Torrent Pharmaceuticals has opted out of the bid for Sanofi’s European generic business, which was valued at € 2 billion (Rs 160 ...
 Business Standard2 weeks ago Torrent may raise Rs 15 bn via QIP as it readies to bid for Sanofi assets  Business Standard1 month ago Torrent Pharma in talks to raise Rs 1,500 crore for Sanofi generics business bid: Report  Money Control1 month ago News Live: Eyeing Sanofi generics biz, Torrent Pharma may raise Rs 1,500cr, says report  Money Control1 month ago

Volumes soar at Sanofi India Ltd counter

Sanofi India Ltd recorded volume of 16520 shares by 10:53 IST on BSE, a 100.21 times surge over two-week average daily volume of 165 shares. The stock gained 0.40% to Rs.5,127.4
 Business Standard1 week ago Volumes jump at Sanofi India Ltd counter  Business Standard1 month ago

Natco Pharma rises 3% on launch of first generic version of Teriflunomide

Teriflunomide is sold by Sanofi - Genzyme under brand name of AUBAGIO, in the USA market.
 Money Control1 week ago
Business Standard

We see ourselves partnering with the govt on healthcare: Sanofi India MD

In a Q&A, N Rajaram says his firm has put the impact of GST behind it and is happy the govt's healthcare policies are becoming more predictable Gireesh Babu | Chennai Last Updated at March 2, 2018 12:49 IST N Rajaram, MD, Sanofi India.jpg Soon after N Rajaram ...
 Business Standard1 month ago

Sanofi launches new diabetes treatment insulin in India

today said it has launched diabetes treatment 'Toujeo' insulin in the country. The product, which is a next generation basal insulin, is a once-daily long-acting basal analog insulin that improves glycemic control in adults with type 1 and type 2 diabetes.
 Money Control2 months ago

Healthcare group Sanofi to invest 350 million euros in Canada vaccine facility

PARIS (Reuters) - French healthcare group Sanofi is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, which the drugmaker said would help it meet growing demand in this area.
 Reuters1 week ago

European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab

PARIS (Reuters) - The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.
 Reuters2 weeks ago Sanofi and partner seek European Medicines Agency review for sleep sickness product  Reuters2 months ago

Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?

(Reuters) - A potent, expensive cholesterol drug sold by Regeneron Pharmaceuticals and Sanofi significantly reduced major adverse heart events in a huge study presented on Saturday but it remains to be seen whether the new data will prompt insurers to pay for ...
 Reuters1 month ago

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.
 Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less